Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Articles
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
Sign in
1 / 120
1 / 120
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12
Mar 02, 2025
Accelerated Approval
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-07
Mar 02, 2025
Continuous
The Future is Continuous: Accelerating the Shift in Biomanufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-08
Mar 02, 2025
Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11
Mar 02, 2025
Structural Biology
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-13
Mar 02, 2025
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10
Mar 02, 2025
Real-World Evidence
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-09
Mar 02, 2025
Orphan Drugs
From Market Failures to Lifesaving Innovations: The Evolution of Orphan Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-06
Mar 02, 2025
Cannabinoids
Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-04
Mar 02, 2025
Biosimilars
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-01
Mar 02, 2025
Microbiome
Harnessing the Human Microbiome: 30 Years of Discovery and Innovation in Biopharma
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-02
Mar 02, 2025
Oncology
From Coley’s Toxins to mRNA: Reflecting on the History of Cancer Vaccines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-03
Mar 02, 2025
Formulation
Overcoming Challenges to High-Concentration Formulation Development
Heonchang Lim
Samsung Biologics
PAO-02-25-CL-19
Mar 02, 2025
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-CL-21
Feb 28, 2025
Fermentation
Achieving Scalable and Sustainable Precision Fermentation Using Process Analytical Technology
Charlotte Hughes, Ph.D.
Hamilton
PAO-02-25-CL-18
Feb 27, 2025
Radioconjugates
Rising Interest in Radioconjugate Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-02-25-CL-20
Feb 25, 2025
Micronization
Meeting the Complex Challenges of Micronization with Experience and Technology
TJ Higley, MSc, MBA
Microsize
PAO-02-25-CL-17
Feb 25, 2025
Federal Job Cuts
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-CL-14
Feb 19, 2025
Lyophilization
Ensuring Biologic Stability with Tailored and Cutting-Edge Lyophilization Solutions
Brecht Vanbillemont, Dr.; Lisa Besslich, Dr. Rer. Nat.
Coriolis Pharma
PAO-02-25-CL-12
Feb 18, 2025
Personalized
Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare
Ola Tuvesson; Isa Lindgren, Ph.D.
NorthX Biologics
PAO-01-25-CL-09
Feb 14, 2025
